Back to top
more

Virtus Kar Health Sciences Fund Cl A: (MF: RAGHX)

(NASDAQ Mutual Funds) As of Apr 24, 2024 08:00 PM ET

$29.54 USD

-0.11 (-0.37%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

3-Hold of 5     3    

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Mar 31, 2024

Total Return %* Percentile Rank Objective
YTD 9.81 25
3 months 9.81 25
6 months 18.10 24
1 Year 12.47 76
3 Year 6.45 35
5 Year 10.32 30
10 Year 10.23 31

* Annual for three years and beyond.

Zacks Premium Research for RAGHX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Hold 3
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 7.88
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 3/31/2024 137.99
% Turnover 3/31/2024 75.00

Risk

3 Year 5 Year 10 Year
Beta 0.82 0.74 0.80
Alpha -2.92 -0.96 -0.05
R Squared 0.70 0.67 0.62
Std. Dev. 17.18 16.65 15.38
Sharpe 0.30 0.58 3.00

Sector / Country Weightings

As of 3/31/2024 % of Portfolio
Health 52.42
Industrial Cyclical 15.06
Services 10.09
Other 9.87
Finance 5.43
Technology 3.64
Retail Trade 3.49

Portfolio Holdings

Top Equity Holdings
(As of 12/31/2023)
% of Portfolio Value (Mil$)
ELI LILLY & CO 9.28 13.21
UNITEDHEALTH GROUP INC 5.43 7.73
IDEXX LABORATORIES INC 4.82 6.86
ABBVIE INC 4.72 6.72
COOPER COMPANIES INC 4.72 6.71
ZOETIS INC 4.42 6.28
MERCK & CO INC 4.08 5.81
VERTEX PHARMACEUTICALS IN 4.04 5.75
WEST PHARMACEUTICAL SERVI 3.94 5.60

Stock Holding % of Net Assets

As Of 12/31/2023
Total Issues 29
Avg. P/E 22.81
Avg. P/Book 4.94
Avg. EPS Growth 10.59
Avg. Market Value (Mil $) 152,986

Allocation

% of Portfolio
Large Growth 7.29
Large Value 14.92
Small Growth 14.42
Small Value 0.00
Foreign Stock 0.35
Emerging Market 11.05
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 7.10